Search

Your search keyword '"Bernard Tawfik"' showing total 52 results

Search Constraints

Start Over You searched for: Author "Bernard Tawfik" Remove constraint Author: "Bernard Tawfik"
52 results on '"Bernard Tawfik"'

Search Results

1. A Remotely Delivered Light-Intensity Physical Activity Intervention for Older Cancer Survivors: Protocol for a Feasibility Randomized Controlled Trial

2. Reaching the 'Hard-to-Reach' Sexual and Gender Diverse Communities for Population-Based Research in Cancer Prevention and Control: Methods for Online Survey Data Collection and Management

3. The RPL/RPS Gene Signature of Melanoma CTCs Associates with Brain Metastasis

5. Data from The RPL/RPS Gene Signature of Melanoma CTCs Associates with Brain Metastasis

6. Improving Outpatient Infusion Clinic Wait Times at a Comprehensive Cancer Center

7. Patient-Reported Measures of a Breast Cancer Nurse Navigator Program in an Underserved, Rural, and Economically Disadvantaged Patient Population

8. Reply to T. Shimoi et al and Y. Shimanuki et al

9. Abstract PS3-24: Using big data to gauge effectiveness of breast cancer awareness month

10. Pharmacist-Driven Oral Oncolytic Medication Education and Consent

11. Abstract P6-11-10: Patient reported measures of a breast cancer nurse navigator program in a minority, rural, and economically disadvantaged patient population

12. Patient, provider, and nurse preferences of patient reported outcomes (PRO) and side effect management during cancer treatment of underrepresented racial and ethnic minority groups, rural and economically disadvantaged patients: a mixed methods study

13. Reaching the 'Hard-to-Reach' Sexual and Gender Diverse Communities for Population-Based Research in Cancer Prevention and Control: Methods for Online Survey Data Collection and Management

14. Abstract A097: Examining differences based on gender and sexual orientation for cervical cancer screening and prevention behaviors

15. Re-induction therapy in adult patients with acute myeloid leukemia with ≤20 % blasts: A retrospective cohort study

16. Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131

17. Examining differences based on gender and sexual orientation for cervical cancer screening and prevention behaviors

18. Evaluating cancer awareness months and cancer screening tests through internet search big data

19. Using big data to gauge effectiveness of breast cancer awareness month

20. Costs of treatment change following first-line somatostatin analog monotherapy among patients with neuroendocrine tumors

21. Developing a survivorship care plan (SCP) delivery process for patients and primary care providers serving poor, rural, and minority patients with cancer

22. Association between glycemic control, age, and outcomes among intensively treated patients with acute myeloid leukemia

23. Utility and proposed algorithm of CSF flow cytometry in hematologic malignancies

24. Patient, provider, and nurse preferences regarding patient-reported outcomes (PRO) and side effect management during cancer treatment of minority, rural and economically disadvantaged patients

25. Ischemic stroke in a patient with moderate to severe inherited factor VII deficiency

26. The neutrophil to albumin ratio as a predictor of pathological complete response in rectal cancer patients following neoadjuvant chemoradiation

27. Cost of treatment change among patients with neuroendocrine tumors (NET) treated originally with somatostatin analogs

28. Streamlining survivorship care plan (SCP) creation and delivery to primary care providers in poor, rural, and minority patients

29. Optimizing infusion wait time: Redesigning medication order verification/approval at a comprehensive cancer center

30. Oral oncolytic education and adherence monitoring in poor, rural and minority patients

31. The Novel Protease-Activated Receptor 1 Antagonist Vorapaxar as a Treatment for Thrombosis in Afibrinogenemia

32. Building a survivorship care plan delivery process: Experience in an academic center

33. Pharmacist-driven oral oncolytic medication education and consent

34. Rates of hepatitis b screening and prophylactic treatment before immunosuppressive therapy in hematological malignancies

35. Effectiveness of biomarker surveillance after treatment in locoregional breast cancer

36. Is there a benefit of re-induction therapy in adult patients with AML with <20% blasts?

37. Implementation of algorithm to guide CSF flow cytometry testing in hematological malignancies

38. House Officer-Driven Reduction in Laboratory Utilization

39. Comorbidity, age and mortality among adults treated intensively for acute myeloid leukemia (AML)

40. Association between glycemic control, age, and outcomes among intensively treated patients with acute myeloid leukemia (AML)

41. Phase II trial of ribociclib and everolimus in p16 low anaplastic thyroid cancer (ATC)

42. Efficacy of the hypomethylating agents as frontline, salvage, or consolidation therapy in adults with acute myeloid leukemia (AML)

43. Retrospective analysis of nadir bone marrow biopsies in predicting need for re-induction therapy in adult acute myeloid leukemia

44. The neutrophil to albumin ratio as predictor of pCR in rectal cancer patients following neoadjuvant chemoradiation

45. Bevacizumab-induced bowel perforation

46. Keratin Biomaterials Activate Schwann Cells via Integrin‐Mediated Signaling and Promote Regeneration of Large Peripheral Nerve Defects in a Rabbit Model

47. Comorbidities, age, and outcomes among intensively treated patients with acute myeloid leukemia (AML)

48. Efficacy of the hypomethylating agents as frontline, salvage, or maintenance therapy among older adults with acute myeloid leukemia (AML)

49. Retrospective review of leukemia cytogenetics and prior malignancies

50. Primary oat cell carcinoma of the larynx: An ultrastructural study

Catalog

Books, media, physical & digital resources